Reliant Pharmaceutical, Liberty Corner, N.J., (908) 580-1200, has gained approval for a new lipid-lowering agent. Antara (fenofibrate) Capsules are indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and ApoB and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb).
FDA Approves Aprocitentan For Treatment of Uncontrolled High Blood Pressure
March 20th 2024Aprocitentan (TRYVIO) from pharmaceutical company Idorsia demonstrated statistically significant and clinically meaningful reductions in blood pressure in combination with other antihypertensive therapies.